3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
52
Leukemia, Myeloid, Acute
49
Lymphoma, Non-Hodgkin
43
Precursor Cell Lymphoblastic Leukemia-Lymphoma
39
Lymphoma
37
Leukemia
35
Hodgkin Disease
35
Myelodysplastic Syndromes
33
Lymphoma, Mantle-Cell
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Lymphoma, Large B-Cell, Diffuse
17
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Burkitt Lymphoma
17
Lymphoma, Follicular
12
Hematologic Neoplasms
12
Neoplasms, Plasma Cell
11
Congenital Abnormalities
11
Lymphoma, B-Cell, Marginal Zone
10
Leukemia, Biphenotypic, Acute
9
Breast Neoplasms
9
Myeloproliferative Disorders
8
Lymphoma, Large-Cell, Immunoblastic
8
Anemia, Refractory, with Excess of Blasts
8
Recurrence
7
Leukemia, Myelomonocytic, Juvenile
7
Leukemia, Myelomonocytic, Chronic
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Graft vs Host Disease
6
Sarcoma
5
Interventions
blinatumomab
6
Cyclophosphamide
5
Rituximab
4
Tacrolimus
3
ponatinib
2
fludarabine
2
denileukin diftitox
2
Vorinostat
2
Vincristine
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Everolimus
2
Etoposide
2
Doxorubicin
2
Darbepoetin alfa
2
Cytarabine
2
Busulfan
2
Brentuximab Vedotin
2
Antilymphocyte Serum
2
Alemtuzumab
2
tetulomab tetraxetan lu-177
1
ruxolitinib
1
pembrolizumab
1
pegaspargase
1
ibrutinib
1
ibritumomab tiuxetan
1
fludarabine phosphate
1
ferrous sulfate
1
ferric gluconate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoproliferative Disorders
×
Granulocyte Colony-Stimulating Factor
×
Clear all
No trials found.